Last updated: September 28, 2022
Sponsor: University of Pennsylvania
Overall Status: Completed
Phase
N/A
Condition
Cardiac Disease
Arrhythmia
Chest Pain
Treatment
N/AClinical Study ID
NCT03691571
831401
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients above the age of 18 years old.
- Patients with the diagnosis of atrial fibrillation undergoing clinically indicatedde-novo AF ablation procedure.
- Patients must be able to understand and critically review the informed consent form.
Exclusion
Exclusion Criteria:
- Patients whom are unable to provide informed consent.
- Patients with contraindication to EGD.
- History of prior AF ablation procedures.
- Significant co-morbidities that preclude standard ablation procedure.
- Patient is ineligible for EnsoETM placement due to:
- Known esophageal deformity or evidence of esophageal trauma (for example historyof esophagectomy, previous swallowing disorders, achalasia).
- Known ingestion of acidic or caustic poisons within the prior 24 hours.
- Patients with <40 kg of body mass.
Study Design
Total Participants: 55
Study Start date:
October 11, 2018
Estimated Completion Date:
February 28, 2021
Study Description
Connect with a study center
University of Pennsylvania - Perelman Center
Philadelphia, Pennsylvania 19104
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.